EMIT
EMIT Corporation is a Houston-based medical device company (founded 2009) that designs and sells portable, disposable IV fluid and blood warming devices powered by flameless hydrocarbon combustion, serving military medical, EMS, and recreational warming markets.
- Company typePrivate
- Founded2009
- HeadquartersHouston, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What EMIT does
EMIT Corporation is a commercial-stage medical device company incorporated in January 2009 and headquartered in Houston, Texas. The company designs, manufactures, and sells devices for the treatment and prevention of hypothermia caused by traumatic, environmental, and procedure-related occurrences. Its product portfolio is anchored by the HypothermX HX100 (under 3.0 lbs, more than 4 hours of continuous use) and HypothermX LG (1 lb, approximately 2 hours of continuous use) portable, fully disposable IV fluid and blood warming devices. These systems are fueled with an isobutane/propane mixture and use a flameless hydrocarbon combustion process for heating, allowing operation without external power sources. Complementary products include the StayWarm convective warm air blowing system (for medical, recreational, and military use) and the ETesla high-flow centrifugal pump (used with HypothermX to accelerate infusion and warming).
The underlying technology is exclusively licensed from The University of Texas Health Science Center at Houston and The University of Texas at Austin, and is protected in part by U.S. Patent No. 7,261,557 with additional patents pending. Initial research and development was funded by the United States Army Telemedicine and Advanced Technology Research Center. The HypothermX platform is FDA 510(k)-cleared, CE-marked, and manufactured under ISO 13485:2003/EN ISO 13485:2012 quality system certification; Military Airworthiness, User, and Environmental Testing was completed under the Joint En-route Care Test System funded by Marine Corps System Command.
EMIT generates revenue through hardware sales of disposable devices, combining direct sales to high-end military customers with a select-direct/distributor model for domestic and outside (OUS) markets. Primary served segments are military medical (including U.S. military Special Operations and combat/en-route care) and civilian emergency medical services, with a secondary outdoor/recreational angle via the StayWarm system. Manufacturing is outsourced to clean-room facilities, while EMIT handles raw material procurement, non-sterile sub-assembly and final assembly, labeling, packaging, inventory, and distribution. Approximately $4.06 million has been disclosed across three funding events (CitareTx Investment Partners I in 2011, UT Horizon Fund in 2013, and an undisclosed round in 2018), and the company has only completed a limited product market release to date.
EMIT firmographics
Firmographics- Name
- EMIT
- Legal name
- EMIT Corporation
- Website
- https://emitcorp.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- EMIT Corporation is a Houston-based medical device company (founded 2009) that designs and sells portable, disposable IV fluid and blood warming devices powered by flameless hydrocarbon combustion, serving military medical, EMS, and recreational warming markets.
- Ownership category
- akta.pro rank
Where EMIT is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
EMIT business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Others
Revenue model
- Medical Device Sales: Sale of disposable HypothermX® HX100 and LG fluid warming devices and related products. Products are fully disposable after use.
- Direct Sales to Military: Direct sales of medical devices to high-end military customers for field deployment and emergency medical use.
- Distributor/OUS Sales: Sales through select-direct/distributor model for domestic and outside (OUS) markets.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
EMIT product offering
Product offeringCore offering
EMIT designs, develops, manufactures, and sells portable medical devices for warming IV fluids and blood products to prevent and treat hypothermia. Its HypothermX and LG product lines use patented flameless hydrocarbon combustion that operates without external power, enabling use in combat casualty care, EMS, and trauma settings. The company also offers the StayWarm convective blanket/vest system and the ETesla high-flow centrifugal blood/fluid pump.
Product overview
EMIT offers a portfolio of therapeutic warming medical devices centered on the HypothermX platform. The core offerings include the HypothermX HX100 (long-term use, >4 hours) and HypothermX LG (acute use, ~1 hour) — both portable, disposable IV fluid and blood warming systems using flameless hydrocarbon combustion. The ETesla centrifugal pump serves as an accessory to accelerate infusion and warming. The StayWarm convective warm air system extends temperature management capabilities to medical, recreational, and military settings. Additional temperature management systems are in development for U.S. military Special Operations.
Differentiator
Problem solved
Functional benefit
Brands
- HypothermX HX100: Patent protected portable fluid warming device designed to warm intravenous fluids, blood or blood products infused into a patient to prevent or treat trauma, environmental, procedure related and/or induced hypothermia.
- HypothermX LG
- StayWarm
- ETesla
Products and services
- HypothermX HX100 Portable, battery- and power-free IV fluid and blood warmer weighing under 3.0 lbs, providing 4+ hours of continuous use and warming fluids to set-point in less than 1 minute at 100 ml/min. Uses patented flameless hydrocarbon combustion (U.S. Patent No. 7,261,557) for combat casualty care, EMS, and trauma use.
- HypothermX LG Compact, lightweight variant of the HypothermX platform weighing 1.0 lb and providing 2+ hours of use, designed for portable IV fluid and blood warming via patented flameless hydrocarbon combustion.
- StayWarm
Quantifiable outcome
- HX100 warms up to 5 liters of saline at 15°C or 15 units of packed red blood cells at 5°C to 38°C ± 3°C at 50-200 ml/min
- +3 more outcomes
Companies that use EMIT
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
EMIT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
EMIT partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- The University of Texas Health Science Center at HoustoncoreTechnology exclusively licensed from The University of Texas Health Science Center at Houston, forming the foundation of EMIT's HypothermX® product line and other temperature management systems.
- The University of Texas at AustincoreTechnology exclusively licensed from The University of Texas at Austin, contributing to EMIT's core patent-protected warming technology.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
EMIT competitors and assessment
Company assessmentBroad incumbents
- Stryker: Stryker is a broad medical device incumbent encompassing surgical equipment, emergency care, and patient handling that overlaps with the trauma and emergency settings where EMIT's products are deployed.
- Teleflex: Teleflex is a diversified medical device company with anesthesia, emergency medicine, and fluid management product lines that overlap with the clinical use cases addressed by EMIT's warming products.
- Becton Dickinson (BD): BD is a major medical device and diagnostics incumbent with infusion therapy and injection systems relevant to the same hospital procurement channels where EMIT's fluid warming devices are sold.
Direct peers
- ICU Medical: ICU Medical acquired Smiths Medical's fluid warming and infusion product lines (e.g., Level 1 fast-flow fluid warmer), making it one of the closest competitors in portable blood and IV fluid warming.
- Belmont Medical Technologies: Belmont specializes in rapid infusion and blood/fluid warming devices (e.g., Belmont Rapid Infuser), directly competing with EMIT's HypothermX platform for IV fluid and blood warming indications.
- Biegler GmbH: Biegler manufactures blood and infusion warmers widely used in European hospitals and emergency medicine, offering a competing technology approach to EMIT's HypothermX for fluid warming.
- 3M: 3M's Bair Hugger is the dominant forced-air patient warming system in hospitals and surgical settings, directly competing with EMIT's temperature management portfolio across civilian and military applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
EMIT compliance and trust
Trust signalCompliance4 records
EMIT financial estimates
Financial estimateRevenue estimate
Valuation estimate
EMIT leadership team
Management profileNumber of profiles
Profiles2 records
EMIT funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EMIT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EMIT
What does EMIT do?
EMIT designs, develops, manufactures, and sells portable medical devices for warming IV fluids and blood products to prevent and treat hypothermia. Its HypothermX and LG product lines use patented flameless hydrocarbon combustion that operates without external power, enabling use in combat casualty care, EMS, and trauma settings. The company also offers the StayWarm convective blanket/vest system and the ETesla high-flow centrifugal blood/fluid pump.
Is EMIT a public or private company?
EMIT is a private company. It is classified as venture growth investor backed and is currently operating.
When was EMIT founded?
EMIT was founded in 2009. It employs 1 to 10 people.
Where is EMIT based?
EMIT is headquartered in Houston, United States, in the North America region.
How does EMIT make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are direct Sales to Military and distributor/OUS Sales.
Who are EMIT's main competitors?
Broad incumbents on record are Stryker, Teleflex and Becton Dickinson (BD). Direct peers are ICU Medical, Belmont Medical Technologies, Biegler GmbH and 3M.
Does EMIT have an API?
No public API is recorded for EMIT.